Showing results (1271-1280 of 1,449) with videos related to
Sort By:
Pageof 145
Cell Death and Differentiation|October 11, 2014
Proteasome inhibition and oxidative reactions disrupt cellular homeostasis during heme stressF Vallelian, J W Deuel, L Opitz, et al.Drugs|June 20, 2026
Developmental Progress and Future Potential for Inhaled Biologics in the Treatment of Respiratory DiseasesBhupendra Raj Giri, Jamie Erin Spahn, Rawidh Alsaidalani, et al.Pharmaceutics|February 25, 2023
Quality by Design (QbD) Approach for a Nanoparticulate Imiquimod Formulation as an Investigational Medicinal ProductJonas Pielenhofer, Sophie Luise Meiser, Karsten Gogoll, et al.Tissue Engineering. Part A|March 19, 2009
The effect of perfluorocarbon-based artificial oxygen carriers on tissue-engineered tracheaQiang Tan, Ashraf Mohammad El-Badry, Claudio Contaldo, et al.The EMBO Journal|February 21, 2009
GTPase activation of elongation factor EF-Tu by the ribosome during decodingJan-Christian Schuette, Frank V Murphy, Ann C Kelley, et al.ESMO Open|March 5, 2023
Safety and clinical activity of atezolizumab plus erlotinib in patients with non-small-cell lung cancerC M Rudin, A Cervantes, A Dowlati, et al.Advances in Therapy|February 19, 2025
Real-world Outcomes Following Biologic Initiation in US Patients with Chronic Rhinosinusitis with Nasal PolypsAnju Peters, Xiaohui Zhao, Aimee M Near, et al.The Journal of Nutrition, Health & Aging|September 26, 2022
Iron Deficiency and Incident Infections among Community-Dwelling Adults Age 70 Years and Older: Results from the DO-HEALTH StudyP Lanz, M Wieczorek, A Sadlon, et al.European Neurology|March 31, 1998
Cerebrospinal fluid levels of amyloid precursor protein and amyloid beta-peptide in Alzheimer's disease and major depression - inverse correlation with dementia severityC Hock, S Golombowski, F Müller-Spahn, et al.Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 24, 2003
Treatment with the selective muscarinic m1 agonist talsaclidine decreases cerebrospinal fluid levels of A beta 42 in patients with Alzheimer's diseaseChristoph Hock, Alessia Maddalena, Andreas Raschig, et al.Pageof 145